BlackRock Fund Advisors’s Alder Biopharmaceuticals ALDR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q4
$44.4M Buy
2,133,222
+278,278
+15% +$7.24M 0.01% 1759
2016
Q3
$60.8M Buy
1,854,944
+100,431
+6% +$3.06M 0.01% 1439
2016
Q2
$43.8M Buy
1,754,513
+617,690
+54% +$16.7M 0.01% 1581
2016
Q1
$27.8M Buy
1,136,823
+45,908
+4% +$1.06M 0.01% 1795
2015
Q4
$36M Sell
1,090,915
-82,739
-7% -$2.8M 0.01% 1701
2015
Q3
$38.4M Buy
1,173,654
+195,017
+20% +$8.29M 0.01% 1589
2015
Q2
$51.8M Buy
978,637
+224,075
+30% +$8.15M 0.01% 1506
2015
Q1
$21.8M Buy
754,562
+170,980
+29% +$4.69M 0.01% 2025
2014
Q4
$17M Buy
583,582
+394,513
+209% +$7.08M ﹤0.01% 2159
2014
Q3
$2.4M Sell
189,069
-7,839
-4% -$118K ﹤0.01% 3095
2014
Q2
$3.95M Buy
+196,908
New +$2.77M ﹤0.01% 2961

Other funds holding ALDR